Edwards Lifesciences

Yahoo Finance • 6 days ago

Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Low Volatility Blue Chip Stocks to Buy Now.Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now On April 7, Citi lifted its price... Full story

Yahoo Finance • 14 days ago

Assessing Edwards Lifesciences (EW) Valuation As Growth Hopes Contrast With Rich P/E Multiple

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Edwards Lifesciences (EW) Is On Investors’ Radar Today Edward... Full story

Yahoo Finance • 19 days ago

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair

Royal Philips Physician using DeviceGuide with EchoNavigator 5Physician using DeviceGuide with EchoNavigator 5·GlobeNewswire Inc. Philips DeviceGuide with EchoNavigator 5 ScreenPhilips DeviceGuide with EchoNavigator 5 Screen·GlobeNewswir... Full story

Yahoo Finance • 23 days ago

Citi's top large-cap stocks with positive ROE trends

[Group of confident business people point to graphs and charts to analyze market data, balance sheet, account, net profit to plan new sales strategies to increase production capacity.] David Gyung/iStock via Getty Images Citi has updated... Full story

Yahoo Finance • 24 days ago

Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now?

Is EW a good stock to buy? We came across a bullish thesis on Edwards Lifesciences Corporation Torre Financial Newsletter’s Substack by Federico Torre. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corpor... Full story

Yahoo Finance • 30 days ago

This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares

On February 17, 2026, OrbiMed Advisors reported selling 143,304 shares of Sionna Therapeutics(NASDAQ:SION), an estimated $5.43 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commiss... Full story

Yahoo Finance • 30 days ago

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share

On February 17, 2026, OrbiMed Advisors disclosed a buy of 556,273 shares of RAPT, with an estimated transaction value of $17.28 million based on quarterly average pricing. What happened According to a Securities and Exchange Commission (... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day

IRVINE, Calif., February 13, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi’s Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financia... Full story

Yahoo Finance • 2 months ago

Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments

Edwards Lifesciences stock wavered Wednesday, though the heart-valve replacement maker issued a bullish outlook for 2026. Continue Reading... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says

Edwards Lifesciences' (EW) high-end guidance targets for 2026 are achievable given multiple catalyst PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences outlines 8%–10% sales growth and $2.90–$3.05 EPS guidance for 2026 while advancing SAPIEN and TMTT platforms

Earnings Call Insights: Edwards Lifesciences Corporation (EW) Q4 2025 MANAGEMENT VIEW * CEO Bernard Zovighian introduced Gerianne Sarte as the new Head of Investor Relations and stated, "We delivered a strong quarter, growing at 11.6%... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter

Edwards Lifesciences stock rose late Tuesday after earnings missed forecasts but fourth-quarter sales beat. Continue Reading... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., February 10, 2026--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025. Highlights and Outlook Q4 sales grew 13.3% to $1.57 billion1, constan... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences Q4 2025 Earnings Preview

* Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) is scheduled to announce Q4 earnings results on Tuesday, February 10th, after market close. * The consensus EPS estimate is $0.62 [https://seekingalpha.com/symbol/EW/earn... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

IRVINE, Calif., February 03, 2026--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

IRVINE, Calif., February 02, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 46th Annual Health Care Conference on Monday, Mar. 2, 2026. Scott Ullem, chief financial o... Full story

Yahoo Finance • 4 months ago

Edwards Lifesciences upgraded at JP Morgan on TAVR, TMTT strength

[Wall Street sign in Lower Manhattan, NYC] georgeclerk JP Morgan upgraded Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replace... Full story

Yahoo Finance • 4 months ago

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., December 18, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive offi... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story